09/30/2024 4:01 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2024 3:23 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2024 3:06 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:30 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/10/2024 11:11 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 3:31 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 12:16 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/12/2024 10:35 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024 3:38 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:04 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 9:54 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 4:35 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 4:14 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 3:38 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:28 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:30 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 9:28 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 5:04 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:10 PM | Crinetics Pharmaceuticals (Subject) Hassard James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024 12:07 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024 3:32 PM | Crinetics Pharmaceuticals (Issuer) Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 4:31 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:32 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:03 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 10:01 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 5:07 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 4:08 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:24 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 3:45 PM | Crinetics Pharmaceuticals (Filer)
| Form S-3ASR | |
06/21/2024 3:31 PM | Crinetics Pharmaceuticals (Subject) Hassard James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 3:35 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:30 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 10:55 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2024 12:44 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 7:23 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 5:29 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 3:47 PM | Crinetics Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024 3:48 PM | Crinetics Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024 3:50 PM | Crinetics Pharmaceuticals (Filer)
| Form ARS | |
Next opportunity for crypto millions (Ad) The floodgates have opened.
Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto.
But most investors are missing the real goldmine…
Go here to discover the crypto that's about to leave Wall Street in the dust. |
04/22/2024 4:23 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:09 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:52 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 3:17 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:31 PM | Crinetics Pharmaceuticals (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 1:34 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024 4:20 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 5:31 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:32 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:33 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:34 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:35 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:37 PM | Crinetics Pharmaceuticals (Subject) Fust Matthew K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:40 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 5:31 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 3:15 PM | Crinetics Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/11/2024 2:34 PM | Crinetics Pharmaceuticals (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
03/06/2024 7:18 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:59 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:57 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:05 PM | Crinetics Pharmaceuticals (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/01/2024 3:41 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 POS | |
02/28/2024 3:31 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 5:36 PM | Crinetics Pharmaceuticals (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:54 AM | Crinetics Pharmaceuticals (Subject) DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:50 AM | Crinetics Pharmaceuticals (Subject) FMR LLC (Filed by)
| Form SC 13G | |
01/26/2024 4:50 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 9:28 AM | Crinetics Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/12/2024 3:12 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 11:10 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:03 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:43 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 4:20 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 10:47 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 5:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:28 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 3:37 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 3:44 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 12:48 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 3:31 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Next opportunity for crypto millions (Ad) The floodgates have opened.
Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto.
But most investors are missing the real goldmine…
Go here to discover the crypto that's about to leave Wall Street in the dust. |
11/27/2023 10:40 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 3:33 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:31 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2023 5:02 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 6:38 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023 4:01 PM | Crinetics Pharmaceuticals (Issuer) Krasner Alan Seth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:20 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |